01/08/2001 (Agence Europe) - The European Commission has given the go-ahead for the placing on the market in the European Union of Ketek, first new family of large-spectrum antibiotics (ketolides), intended to combat Community infections acquired through inferior and superior respiratory paths, by combating bacteria resistant to existing treatments (macrolides, penicillin). The approval for placing on the market follows a favourable opinion passed down in March by the Scientific Committee of...